Product Information
DILTIAZEM 30 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0508 per EA under NDC 00093031805. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
30 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093031805
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074185On Market Since
12/22/1995
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 30 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0508 per EA |
|---|---|
| All-time high | $0.1221 (Mar 15, 2017) |
| All-time low | $0.0505 (Jul 17, 2024) |
| 52-week high | $0.0581 |
| 52-week low | $0.0508 |
| Median price | $0.0955 |
| Average price | $0.0886 |
| Largest weekly change | +56.6% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DILTIAZEM 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 30 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0508 per EA (NDC 00093031805), effective Jun 24, 2026.
How has the price of DILTIAZEM 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 30 MG TABLET has declined 5.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 30 MG TABLET?
Since Nov 28, 2013, the NADAC for DILTIAZEM 30 MG TABLET has ranged from a low of $0.0505 (Jul 17, 2024) to a high of $0.1221 (Mar 15, 2017), with a median of $0.0955 per EA.
Are there cheaper alternatives to DILTIAZEM 30 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as DILTIAZEM 30 MG TABLET, but none are currently priced below it.
Who manufactures DILTIAZEM 30 MG TABLET?
DILTIAZEM 30 MG TABLET (NDC 00093031805) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification